JT
DFTX

Jupiter Topco’s Definium Therapeutics DFTX Stock Holding History

Jupiter Topco’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264M Buy
+5,615,645
New +$139M 0.11% 177

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jupiter Topco's DFTX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 5,615,645 shares worth $264M. The stake represents 0.11% of the portfolio and ranks #177 among its holdings.

340 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Jupiter Topco held 5,615,645 shares of Definium Therapeutics worth $264M as of Q2 2026.
  • Definium Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Definium Therapeutics made up 0.11% of Jupiter Topco's portfolio in Q2 2026, its #177 holding.
  • 340 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.